Article | bit.bio adds $100M+ investments and board of directors

November 5, 2021 | Published by bit.bio

Gregory and Mark-min

On the left Sir Gregory Paul Winter CBE FRS FMedSci, Nobel Prize-winning British molecular biologist and bit.bio's board member, right Dr Mark Kotter Founder and CEO bit.bio 

CAMBRIDGE, UK, Friday 5 November 2021 - bit.bio CEO Dr Mark Kotter was interviewed by END Points on bit.bio's $103m Series B fundraise and board appointments.

Mark Kotter 
“I’m not going to say this is going to be easy. It’s going to be super hard, but our advantage is that we’re not fighting a biology that is resisting, you know, scale up and consistency.”
Mark Kotter

Founder and CEO

 

Read the full Endpoints News article. 

 

Latest news